HPV Prevention and Control Board

HPV Vaccination of Adults: Impact, Opportunities and Challenges

November 2019 - Antwerp, Belgium

Meeting objectives:

  • Provide an overview of the current situation of the HPV vaccine for adults.
  • Discuss the immunogenicity, safety and efficacy data of existing HPV vaccine studies in adults.
  • Gain insight into the efficacy of the HPV vaccine at the mucosal level and systemic level.
  • Discuss ways and methods to conduct research on the potential benefits of vaccinating exposed adults.
  • Discuss the challenges and benefits of vaccination of adults including high risk groups.
  • Discuss cervical cancer elimination strategies.
  • Discuss the potential implications of vaccination of adults on vaccine supplies in Low and Middle-Income Countries (LMIC).

November 14, 2019

OPENING AND OBJECTIVES

  • . (Pdf, 1.600 kB)
    Alex Vorsters

SESSION 1: SITUATIONAL ANALYSIS OF HPV VACCINATION OF ADULTS: IMUNOGENECITY AND SAFETY DATA
Chairs: Alex Vorsters & Pierre Van Damme

  • Efficacy and safety of prophylactic HPV vaccination in adults.
    Marc Arbyn
     
  •  (Pdf, 726 kB)
    Tino F. Schwarz
     
  • Questions & Discussion

SESSION 2: HPV IMMUNOLOGICAL DYNAMICS AT MUCOSAL AND SYSTEMIC LEVEL
Chairs: Mario Poljak & Marc Arbyn

  •  (Pdf, 515 kB)
    John Schiller
     
  •  (Pdf, 2.036 kB)
    Fiona RM van der Klis
     
  •  (Pdf, 1.159 kB)
    Jade Pattyn
     
  • (Pdf, 310 kB)
    Margaret Stanley & Xavier Bosch
     
  • Questions & Discussion

SESSION 3: COMPREHENSIVE ANALYSIS OF CHALLENGES AND POTENTIAL BENEFITS OF HPV VACCINATION OF ADULTS
Chairs:  Eduardo Franco & Iacopo Bausanno

  •  (Pdf, 2.506 kB)
    John Schiller
     
  • .
    Marta del Pino
     
  •  (Pdf, 340 kB)
    Susanne Krüger Kjær
     
  • Questions & Discussion.
     
  •  (Pdf, 733 kB)
    Aaron MacCosham and Eduardo Franco
     
  • Predicting cohort-specific cervical cancer incidence from population-based HPV prevalence surveys.                                          
    Iacopo Bausanno   
     
  •  (Pdf, 682 kB)
    Harrell Chesson
     
  • Questions & Discussion.
     
  • Breakout Session
    Chairs: Paolo Bonanni & Susanne Krüger Kjær

    - Pap smear; an increased risk for HPV infections? – How to deal with it?
    - Are vaccinated women less prone to transmit infections – What are the ways to investigate it?
     
  • Plenary feedback from different groups

November 15, 2019

SESSION 4: HPV VACCINATION OF HIGH-RISK GROUPS
Chairs: Mira Kojouharova & Sharon Hanley​

  •  (Pdf, 649 kB)
    Aaron MacCosham
    Eduardo Franco  
     
  •  (Pdf, 461 kB)
    Maarten Schim van der Loeff 
     
  • . (Pdf, 320 kB)
    Ross Cameron
     
  • Questions & Discussion

SESSION 5: LIMITATIONS AND ELIMINATION GOALS
Chairs: Mark Kane & Luidmila Mosina

  •  (Pdf, 2.826 kB)
    Paul Bloem
     
  • Questions & Discussion

BREAKOUT SESSIONS
Chairs:  Paul Bloem & Emilie Karafillakis

   - Outcome of the meeting, current challenges and strategies to deal with challenges: Where do we stand today? 

  • Plenary feedback from each group and discussion

CONCLUSION OF THE MEETING
Chairs: Pierre Van Damme & Xavier Bosch

  •  (Pdf, 213.74 kB)
     
  • Closing remarks